Open Access
Volume 9, Number 2, June 2019
Article Number 10
Number of page(s) 6
Published online 24 May 2019
  1. Boersma E, Mercado N, Poldermans D, Gardien M, Vos J, Simoons ML. Acute myocardial infarction. Lancet. 2003; 361: 847–58. [CrossRef] [PubMed] [Google Scholar]
  2. Appleby P, Baigent C, Collins R, Flather M, Parish S, Peto R, et al. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet. 1994; 343: 311–22. [CrossRef] [PubMed] [Google Scholar]
  3. Steinman MA, Zullo AR, Lee Y, Daiello LA, Boscardin WJ, Dore DD, et al. Association of β-Blockers With Functional Outcomes, Death, and Rehospitalization in Older Nursing Home Residents After Acute Myocardial Infarction. JAMA Intern Med. 2017; 177: 254–62. [CrossRef] [PubMed] [Google Scholar]
  4. Miyachi H, Takagi A, Miyauchi K, Yamasaki M, Tanaka H, Yoshikawa M, et al. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort Heart Vessels. 2016; 31: 1740–51. [CrossRef] [PubMed] [Google Scholar]
  5. Paolasso E, Martin ES, Ravizzini G, R Díaz, Covelli G, Romero G, et al. Randomized trial of late thrombolysis in patients with suspected acute myocardial infarction. Lancet. 1993; 342: 767–72. [CrossRef] [PubMed] [Google Scholar]
  6. Hampton J, Wilcox R, Armstrong P, Aylward P, Bett N, Charbonnier B, et al. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6–24 hours after onset of acute myocardial infarction. Lancet. 1993; 342: 759–66. [CrossRef] [PubMed] [Google Scholar]
  7. Yang KC, Yamada KA, Patel AY, Topkara VK, George I, Cheema FH, et al. Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support. Circulation. 2014; 129: 1009–21. [CrossRef] [PubMed] [Google Scholar]
  8. Kitabata H, Kubo T, Ishibashi K, Komukai K, Tanimoto T, Ino Y, et al.. Prognostic value of microvascular resistance index immediately after primary percutaneous coronary intervention on left ventricular remodeling in patients with reperfused anterior acute ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2013; 6: 1046–54. [CrossRef] [PubMed] [Google Scholar]
  9. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, J O’Keefe, et al.. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med. 1993; 328: 673–9. [CrossRef] [PubMed] [Google Scholar]
  10. A Schömig, Kastrati A, Dirschinger J, Mehilli J, Schricke U, Pache J, et al.. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. N Engl J Med.. 2000; 343: 385–91. [CrossRef] [PubMed] [Google Scholar]
  11. Kastrati A, Mehilli J, Dirschinger J, Schricke U, Neverve J, Pache J, et al.. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial. Lancet. 2002; 359: 920–5. [CrossRef] [PubMed] [Google Scholar]
  12. Keeley EC, Boura JA, Grines CL Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003; 361: 13–20. [CrossRef] [PubMed] [Google Scholar]
  13. Nallamothu BK, Antman EM, Bates ER. Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment?. Am J Cardiol. 2004; 94: 772–4. [CrossRef] [PubMed] [Google Scholar]
  14. Brodie BR, Stone GW, Cox DA, Stuckey TD, Turco M, Tcheng JE, et al. Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trial. Am Heart J. 2006; 151: 1231–8. [CrossRef] [PubMed] [Google Scholar]
  15. Gibler WB, Armstrong PW, Ohman EM, Weaver WD, Stebbins AL, Gore JM, et al. Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience. Ann Emerg Med. 2002; 39: 123–30. [CrossRef] [PubMed] [Google Scholar]
  16. Li J, Li X, Wang Q, Hu S, Wang Y, Masoudi FA, et al. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data. Lancet. 2015; 385: 441–51. [CrossRef] [PubMed] [Google Scholar]
  17. Gao R, Patel A, Gao W, Hu D, Huang D, Kong L, et al. Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes. Heart. 2008; 94: 554–60. [CrossRef] [PubMed] [Google Scholar]
  18. Valuckiene Z, Budrys P, Jurkevicius R Predicting ischemic mitral regurgitation in patients with acute ST-elevation myocardial infarction: Does time to reperfusion really matter and what is the role of collateral circulation?. Int J Cardiol. 2016; 203: 667–71. [CrossRef] [PubMed] [Google Scholar]
  19. Xiang DC, Duan TB, Qin WY, Luo WS, Zhang JX, Yi SD, et al. Impacts of establishment of chest pain center on the door-to-balloon time and the short-term outcome after primary percutaneous coronary intervention of patients with ST segment elevated myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi. 2013; 41: 568–71. [PubMed] [Google Scholar]
  20. Parikh SV, Treichler DB, DePaola S, Sharpe J, Valdes M, Addo T, et al. Systems-Based Improvement in Door-to-Balloon Times at a Large Urban Teaching Hospital A Follow-Up Study From Parkland Health and Hospital System. Circ Cardiovasc Qual Outcomes. 2009; 2: 116–22. [Google Scholar]
  21. N Abi Rafeh, D Abi-Fadel, Wetz RV, Khoueiry G, Azab B, Edwards A, et al. A STEMI code protocol improves door-to-balloon time on weekdays and weekends. J Healthc Qual .2009; 31: 35–43. [CrossRef] [PubMed] [Google Scholar]
  22. Phelan MP, Glauser J, Smith E, Martin C, Schrump S, Mahone P, et al. Improving emergency department door-to-electrocardiogram time in ST segment elevation myocardial infarction. Crit Pathw Cardiol. 2009; 8: 119–21. [CrossRef] [PubMed] [Google Scholar]
  23. Huang RL, Donelli A, Byrd J, Mickiewicz MA, Slovis C, Roumie C, et al. Using Quality Improvement Methods to Improve Door-to-Balloon Time at an Academic Medical Center. J Invasive Cardiol. 2008; 20: 46–52. [Google Scholar]
  24. Bradley EH, Herrin J, Wang Y, Barton BA, Webster TR, Mattera JA, et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med. 2006; 355: 2308–20. [CrossRef] [PubMed] [Google Scholar]
  25. Bradley EH, Nallamothu BK, Curtis JP, Webster TR, Magid DJ, Granger CB, et al. Summary of evidence regarding hospital strategies to reduce door-to-balloon times for patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Crit Pathw Cardiol. (2007; 6: 91–7. [CrossRef] [PubMed] [Google Scholar]
  26. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003; 349: 733–42. [CrossRef] [PubMed] [Google Scholar]
  27. Kushner FG, Hand M, SC SmithJr, SB King3rd, Anderson JL, Antman EM, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009; 120: 2271–306. [CrossRef] [PubMed] [Google Scholar]
  28. Xu B, Betancor J, Asher C, Rosario A, Klein A. Congenital Absence of the Pericardium: A Systematic Approach to Diagnosis and Management. Cardiology. 2016; 136: 270–8. [Google Scholar]
  29. Antman EM. Time is muscle: translation into practice. J Am Coll Cardiol. 2008; 52: 1216–21. [CrossRef] [PubMed] [Google Scholar]
  30. Payne KB, Wharrad H, Watts K. Smartphone and medical related App use among medical students and junior doctors in the United Kingdom (UK): a regional survey. BMC Med Inform Decis Mak. 2012; 12: 121. [CrossRef] [PubMed] [Google Scholar]
  31. N Al-Hadithy, Gikas PD, SS Al-Nammari. Smartphones in orthopaedics. Int Orthop.. 2012; 36: 1543–7. [CrossRef] [PubMed] [Google Scholar]
  32. Goost H, Witten J, Heck A, Hadizadeh DR, Weber O, I Gräff, et al. Image and diagnosis quality of X-ray image transmission via cell phone camera: a project study evaluating quality and reliability. PLoS One. 2012; 7: e43402. [CrossRef] [PubMed] [Google Scholar]
  33. Astarcioglu MA, Sen T, Kilit C, Durmus HI, Gozubuyuk G, Kalcik M, et al. Time-to-reperfusion in STEMI undergoing interhospital transfer using smartphone and WhatsApp messenger. Am J Emerg Med. 2015; 33: 1382–4. [Google Scholar]
  34. PT O’Gara, Kushner FG, Ascheim DD, DE CaseyJr, Chung MK, JA de Lemos, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 127: 529–55. [CrossRef] [PubMed] [Google Scholar]
  35. Fox KA, Steg PG, Eagle KA, Goodman SG, FA AndersonJr, Granger CB, et al.. Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006. JAMA. 2007; 297: 1892–900. [CrossRef] [PubMed] [Google Scholar]
  36. Harris M, Karamasis GV, Chotai S, Tang KH, Clesham GJ, Kelly PA. Spinal cord infarction post cardiac arrest in STEMI: A potential complication of intra-aortic balloon pump use. Acute Card Care. 2016; 13: 1–4. [Google Scholar]
  37. J Navarro-Cuartero, JG Córdoba-Soriano, J Jiménez-Mazuecos, A Gutiérrez-Díez, A Gallardo-López, Melehi D. Incidence and Prognosis of Mechanical Complications of STEMI After Primary Angioplasty: Data From a Single-center Registry of an Infarction Code Program. Rev Esp Cardiol. 2016; 69: 874–6. [CrossRef] [PubMed] [Google Scholar]
  38. Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000; 283: 2941–7. [CrossRef] [PubMed] [Google Scholar]
  39. GA de Waard, Hollander MR, Teunissen PF, Jansen MF, Eerenberg ES, Beek AM, et al. Changes in Coronary Blood Flow After Acute Myocardial Infarction: Insights From a Patient Study and an Experimental Porcine Model. JACC Cardiovasc Interv. 2016; 9: 602–13. [CrossRef] [PubMed] [Google Scholar]
  40. Pan W, Zhao D, Zhang C, Li W, Yu J, Wang S, et al. Application of neutrophil/lymphocyte ratio in predicting coronary blood flow and mortality in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention. J Cardiol. 2015; 66: 9–14. [Google Scholar]